CNN producer believes Alzheimer’s is “inherently a national story”
The topic of Alzheimer’s disease has always been a personal one for CNN.com Health producer Elizabeth Landau. Her grandmother suffered from Alzheimer’s, and the effects of her disease took a toll on Landau’s entire family. Landau’s grandmother passed away in 2007, and Landau has been interested in reporting on Alzheimer’s research ever since.
Landau earned her master’s in journalism from Columbia University before starting out with CNN as a Master’s Fellow in 2007. She returned in 2008 after interning for Dow Jones and writing for law360.com, and was promoted to CNN.com health writer in June that same year. In May, she participated in the NPF program Alzheimer’s Issues 2011, which focused on ethical issues, global aging and the personal cost to care-givers.
J2J Fellow Takes On China’s Health Problems
Thomson Reuters correspondent Sui-lee Wee works in a country where health issues are at the forefront of the public discussion and a matter of international scrutiny. Sui-Lee started out covering the Southeast Asian stock markets before completing her master’s degree in business journalism at New York University in 2008. She now covers politics and general news in China, but also deals with human rights and health issues.
AIDS Drugs: What about side effects?
0 comments
This is a guest post by Kenny Goldberg, health reporter for KPBS News in San Diego. He is a former J2J fellow.
The results of three new studies about the effectiveness of daily use of the medication tenofovir, Truvada and other drugs to prevent transmission of HIV are impressive. The idea that a pill could act as a prophylactic against the spread of the virus has been a longtime dream.
But as anyone who’s been covering the epidemic knows, when it comes to antiretroviral drugs, there is no free lunch. All medications have side effects. As journalists responsible for reporting on advances in the field, we need to communicate those risks and put them in their proper context.
Story Ideas for Journalists from Rome (IAS 2011)
0 comments
ROME – A wealth of potential story ideas came out of the Rome AIDS conference. This is a list I discussed with people attending a media briefing organized by the IAS prior to the conference. What are the ideas you’d like to share? Fill in the comment box at the end of this post.
The BIG story coming out of the Rome AIDS conference were the results from three separate trials seeking to determine of available drugs used for the treatment of HIV could be used for the prevention of transmission.
What the HIV Experience Can Teach the NCD Community
0 comments
ROME – The AIDS Conference held here may have opened a window onto the next big story in public health issues – the benefit for the non-communicable disease community in building on the infrastructure that the HIV/AIDS community has spent 30 years putting into place.
The show-stoppers at the conference were the three trials that show that drugs like tenofovir and others, when used in certain combinations, can prevent the transmission of the AIDS virus (see a blog post I did after the conference that has many links to critical information).
But there was a great deal of buzz before and during the Rome conference on the anticipated attention about to be paid diseases other than AIDS.
Earlier Blog Posts
-
Lowering the Cost of AIDS Drugs While Searching for…
July 29, 2011 -
Tobacco Usage and India - A Q&A with J2J fellow…
June 15, 2011 -
AIDS 2010 Wrap Up, Story Ideas for the Future
August 3, 2010 -
AIDS 2010: An Embargo Gone Bust
July 21, 2010 -
AIDS 2010: Inside The Media Center
July 21, 2010
